Holen Sie sich die Stockscreener-App
22.84
23.23%
-6.91
Schlusskurs vom Vortag:
$29.75
Offen:
$29.75
24-Stunden-Volumen:
26,919
Relative Volume:
9.28
Marktkapitalisierung:
$20.90M
Einnahmen:
$226.00K
Nettoeinkommen (Verlust:
$-20.18M
KGV:
-23.55
EPS:
-0.97
Netto-Cashflow:
$-17.40M
1W Leistung:
-22.13%
1M Leistung:
+2,195%
6M Leistung:
+2,195%
1J Leistung:
+2,195%
1-Tages-Spanne:
$20.90
$29.75
1-Wochen-Bereich:
$20.90
$43.14
52-Wochen-Spanne:
$20.90
$43.14
Onconova Therapeutics Inc Stock (ONTX) Company Profile
Firmenname
Onconova Therapeutics Inc
Sektor
Branche
Telefon
267 759 3680
Adresse
12 Penns Trail, Newtown, PA
Compare ONTX vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ONTX
Onconova Therapeutics Inc
|
22.84 | 20.90M | 226.00K | -20.18M | -17.40M | -0.97 |
VRTX
Vertex Pharmaceuticals Inc
|
528.04 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
654.27 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
939.68 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
312.78 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.24 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Onconova Therapeutics Inc Stock (ONTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-03-01 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2021-05-18 | Eingeleitet | Guggenheim | Buy |
| 2018-03-01 | Bestätigt | H.C. Wainwright | Buy |
| 2018-01-17 | Herabstufung | Maxim Group | Buy → Hold |
| 2017-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-04-27 | Eingeleitet | Laidlaw | Buy |
| 2015-07-01 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2015-05-05 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Onconova Therapeutics Inc Aktie (ONTX) Neueste Nachrichten
TRAWTraws Pharma Inc Stock Price and Quote - Finviz
Pharmazz, Inc. Appoints Ajay Bansal as Chief Financial Officer - Yahoo Finance
Q4 2025 Traws Pharma Inc Earnings Call Transcript - GuruFocus
News | postregister.comOnconova Therapeutics, Inc.Common Stock (Nasdaq:ONTX) Stock Quote - FinancialContent
TransCode Therapeutics Appoints Jack E. Stover To Board - citybiz
TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors - WV News
PI3K Inhibitors Clinical Trials Analysis 2025: Pipeline Analysis, Competitive Landscape, Emerging Therapies, Companies, and Future Outlook by DelveInsight - The Globe and Mail
Annovis Appoints Mark Guerin as Chief Financial Officer - citybiz
Rigosertib Shows Promise in EB-Associated Skin Cancer - Medscape
ONTX Stock Price, News & Analysis - Stock Titan
Huadong Medicine and Synerk to jointly develop siRNA drug - BioWorld MedTech
Onconova Therapeutics (NASDAQ: ONTXW)Share Price - intelligentinvestor.com.au
‘Best-In-Class Virology And Oncology’: Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Combine to Form Traws Pharma, Inc. - orrick.com
Traws Pharma (TRAW) Stock Price, News & Analysis - MarketBeat
10 High-Volume Penny Stocks and Trading Strategies - StocksToTrade
Onconova and Trawsfynydd merge to form Traws Pharma By Investing.com - Investing.com UK
PI3K Inhibitors Clinical Trial Pipeline Experiences - GlobeNewswire
We Think Onconova Therapeutics (NASDAQ:ONTX) Needs To Drive Business Growth Carefully - Yahoo Finance
News - FinancialContent
Zim Doctor Appointed Chief Medical Officer in UK - ZimEye
Onconova Therapeutics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference - FinancialContent
Penny Stocks To Buy Now? 5 With Big News Today - PennyStocks.com
Onconova Therapeutics Touts Additional Positive Data For Rigosertib Monotherapy In Skin Cancer Setting - Yahoo Finance
Onconova Therapeutics Appoints Drs. Peter Atadja and Trafford Clarke to its Board of Directors - citybiz
ONCONOVA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.com
Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter Financial Results on August 11, 2022 - The Globe and Mail
Corgi Onto 2X Daily ETF (ONTX-A) Stock Price and News - The Globe and Mail
Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug - Yahoo Finance
Targeting the Immune System and Beyond: The Potential for Safe and Durable Responses in Higher-Risk Myelodysplastic Syndromes with Immuno-Myeloid Therapy - European Medical Journal
ONCONOVA THERAPEUTICS : ANNOUNCES PRICING OF $21 MILLION PUBLIC OFFERING OF COMMON STOCK - marketscreener.com
ONTX stock dives 16%, DVAX stock in green after clinical data - Kalkine Media
What's going on in today's pre-market session - ChartMill
Onconova Therapeutics Announces the Appointment of Mark Gelder, M.D., as Chief Medical Officer - GlobeNewswire
Why Onconova Therapeutics (ONTX) Stock Is Up Sharply - Market Realist
Onconova Therapeutics (ONTX) Stock Live Price, Chart & News - CoinCodex
ONTX Stock: Why Biopharma Onconova Therapeutics Is Shooting Higher Today - InvestorPlace
PrimoHoagies is on a roll, adding 21 stores, while Penn-backed Carisma raises cash to fight cancer - Inquirer.com
Novel CDK4/6 Inhibitor ON 123300 Receives Green Light to Move Into Phase 1 Testing in Relapsed/Refractory Advanced Cancers - OncLive
Onconova Therapeutics Appoints James J. Marino, JD, MBA as Chairman of the Board of Directors - citybiz
Onconova On The Edge After Phase III Rigosertib MDS Failure - Citeline News & Insights
Are These On Your List Of Penny Stocks To Trade This Week? - PennyStocks.com
Penny Stocks To Watch Before Next Week; 1 Up Over 370% In June 2020 - PennyStocks.com
Onconova Therapeutics Inc Files For Mixed Shelf Of Up To $150 Million - Reuters
ONTX Stock Price, Quote & Chart | ONCONOVA THERAPEUTICS INC (NASDAQ:ONTX) - ChartMill
ONCONOVA THERAPEUTICS INC (ONTX) Stock Technical Analysis - Chartmill
Bucks County biopharm firm names new CEO - The Business Journals
Onconova Therapeutics Announces New CEO Appointment - Global Banking & Finance Review
Hedge Fund and Insider Trading News: Michael Novogratz, Ray Dalio, Onconova Therapeutics Inc. (ONTX), Cerecor Inc (CERC), Spirit of Texas Bancshares Inc (STXB), L3 Technologies Inc (LLL), and More - Insider Monkey
Onconova Therapeutics Announces License Agreement With Pint Pharma To Commercialize Rigosertib - Reuters
Onconova Therapeutics Announces Closing of $10 Million - GlobeNewswire
Onconova Moving Forward with Phase 3 INSPIRE Pivotal Trial - GlobeNewswire
Finanzdaten der Onconova Therapeutics Inc-Aktie (ONTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):